Personal Care Products

CHICMAX

Shangmei Shares Jointly Establishes Yufu Tech with Cui Yutao

Shangmei's Annual Revenue Reaches RMB 9.178 Billion with a 35.1% Year-on-Year Increase

CHICMAX released FY2025 9-month earnings on March 26 (BJT), actual revenue HKD 7.219 B, actual EPS HKD 2.2201

CHICMAX released FY2025 Q3 earnings on March 26 (BJT), actual revenue HKD 2.771 B, actual EPS HKD 0.7941

A-Me Shares 2025 Revenue and Profit Significant Growth

CHICMAX released FY2025 Q4 earnings on March 26 After-Market (BJT), actual revenue HKD 2.819 B, actual EPS HKD 0.8078

CHICMAX released FY2025 earnings on March 26 After-Market (BJT), actual revenue HKD 10.03 B (forecast HKD 10.09 B), actual EPS HKD 3.0273 (forecast HKD 3.2051)

CHICMAX to Release FY2025 Earnings on March 26 After-Market (BJT), Forecast Revenue HKD 10.3 B, EPS HKD 3.273

Shanghai Shangmei Co. and Suzhou Jintuo Sign KT-939 Commercialization Cooperation Agreement

OnBeauty Announces 2025 Preliminary Earnings Report

Hansoo Enters Brand Upgrade 3.0 Era and Releases Parent Company's Financial Report

Hansoo Faces Trust Crisis Over Facial Mask Ingredients Controversy

Luoyan Purchased 363,600 H Shares of Shangmei Group

Director Luo Yan frequently 增持 s shares of Shanghai Mei Share

Huatai Securities Maintains Buy Rating on Shanghai Shangmei H Shares

East Money Securities Sees Potential in AmorePacific's Main Brand and New Brands

Shenwan Hongyuan Projects YOY Growth for Shanghai Mei Share's Net Profit from 2025 to 2027

Amei Shares Sees Significant Revenue and Net Profit Growth in 2024

Hanskin Announces Wang Jiarul as Global Brand Ambassador

Shanghai Shangmei Increases Debt But Remains Cash Abundant

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

02145

Shanghai Chicmax Cosmetics Co., Ltd. has announced a final dividend of RMB 0.75 per share for the year ending December 31, 2025, with shareholder approval on May 8, 2026. The dividend will be paid on June 23, 2026, with an ex-dividend date of May 12, 2026. The company clarified tax implications for resident and non-resident shareholders. The latest analyst rating for the stock (HK:2145) is a Buy, with a price target of HK$109.10. Shanghai Chicmax operates in the cosmetics industry, focusing on beauty products for both domestic and international markets.

Tip Ranks

Shanghai Chicmax Updates Final Dividend and Tax Details for 2025 Payout

Shanghai Chicmax Cosmetics Co., Ltd. has scheduled its annual general meeting for May 8, 2026, to review the 2025 annual report and approve the profit distribution plan. Shareholders will vote on renewing auditors, directors’ remuneration, and authorizing credit facilities and H-share buybacks. The company emphasizes governance procedures for shareholder participation. The latest analyst rating for its stock (HK:2145) is a Buy with a price target of HK$109.10. Shanghai Chicmax focuses on the beauty and personal care industry, with its H shares listed in Hong Kong.

Shanghai Chicmax Sets 2026 AGM to Approve 2025 Results, Dividend Plan and H-Share Buyback Mandate

Shanghai Chicmax Cosmetics Co., Ltd. (HK:2145) has announced a final ordinary cash dividend of RMB 0.75 per share for the fiscal year ending December 31, 2025, pending shareholder approval on May 8, 2026. The dividend will be paid on June 23, 2026, to shareholders on record as of May 18, 2026, with an ex-dividend date of May 12, 2026. The company clarified withholding tax arrangements, with rates between 10% and 20% based on shareholder type and domicile. The latest analyst rating for the stock is a Buy, with a price target of HK$109.10.

Shanghai Chicmax Updates Final 2025 Dividend and Withholding Tax Arrangements

Shanghai Chicmax Cosmetic (SEHK:2145) reported strong 2025 earnings with a 41.1% increase in net income and proposed a steady final dividend of RMB 0.75 per share. Despite a recent share price decline, the company trades at a P/E of 16.1x, below its fair P/E of 19.2x and the industry average of 21.3x, suggesting it may be undervalued. However, a DCF analysis indicates the shares could be overvalued at HK$51.2, with an estimated value of HK$42.27. Investors are advised to weigh the trade-offs between growth potential and valuation risks.

Simplywall

Shanghai Chicmax Cosmetic (SEHK:2145) Valuation After Strong 2025 Earnings And Steady Dividend

603605

Zirantang reactivated its IPO listing process on March 29. The updated prospectus shows its 2025 revenue at approximately RMB 5.318 billion, with the gross profit margin rising to 70.6%. Despite ranking tenth in the Chinese cosmetics market with a 0.8% market share, it faces fierce competition from Proya and CHICMAX. Zirantang's revenue growth and net profit have shown significant volatility; however, its net profit in the first half of 2025 has already exceeded the full year of 2024, indicating that its profitability is recovering

- After its IPO application became "invalid" on March 29 due to exceeding the six-month deadline, Naturder updated its financial data and reactivated its listing process.  
- The updated prospectus indicates that while Naturder demonstrated solid financial performance in 2025, it still faces challenges in revenue structure and market positioning amid intense competition from brands like Proya and Shiseido.  
- The company's heavy reliance on its main brand, coupled with a significant gap between marketing and R&D spending, poses risks as the cosmetics industry shifts towards a focus on comprehensive brand strategies and innovation.

Wallstreetcn

Proya

Zirantang Re-attempts IPO

CHICMAX announced its 2025 annual performance, with revenue of 9.178 billion RMB (same below), an increase of 35.1% year-on-year; gross profit of 7.015 billion RMB, an increase of 37.3%. It recorded a net profit of 1.103 billion RMB, a growth of 41.1%, with earnings per share of 2.77 RMB. A final dividend of 0.75 RMB was declared

AASTOCKS

In the "Performance" report, CHICMAX's annual net profit reached 1.103 billion RMB, an increase of 41.1%, with a final dividend of 0.75 yuan

Shanghai Chicmax Cosmetics Co., Ltd. (HK:2145) has announced a final ordinary cash dividend of RMB 0.75 per share for the financial year ending December 31, 2025, pending shareholder approval on May 8, 2026. The dividend will be paid on June 23, 2026, with an ex-dividend date of May 12, 2026. This announcement reflects the company's confidence in its financial performance. The current analyst rating for the stock is a Hold, with a price target of HK$74.00.

Shanghai Chicmax Announces Final Cash Dividend for 2025

00HSI

STECH

00866

36Kr learned that the Hang Seng Index rose by 0.13%, while the Hang Seng TECH Index fell by 0.08%; semiconductor, electrical equipment, and coal stocks led the decline, with SINOHYTEC dropping over 8%, GIGADEVICE falling over 6%, and CHINA QINFA decreasing over 4%; consumer, household goods, and defense military industry sectors saw the largest gains, with CHICMAX rising over 7%, CIRRUS increasing over 5%, and POP MART up over 3%; southbound funds had a net outflow of HKD 11.481 billion

36Kr

Hang Seng Index

Hang Seng TECH Index

CHINA QINFA

POP MART

SINOHYTEC

CIRRUS

GIGADEVICE

Hang Seng TECH ETF I

CAM HS TECH

China Southern Hang Seng TECH ETF(QDII)

Dacheng Hang Seng Technology ETF(QDII)

China Southern Hang Seng ETF

Tianhong Hang Seng TECH ETF(QDII)

CSOP HS TECH

HSTECH ETF

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

ISHARESHSTECH

ChinaAMC Hang Seng Technology ETF(QDII)

The Hang Seng Index closed up 0.13%, while the Hang Seng TECH Index fell 0.08%

Phillip Securities has maintained a Buy rating on Shanghai Chicmax Cosmetics Co., Ltd. Class H, setting a price target of HK$78.64, while the shares closed at HK$56.35. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$103.06.

Phillip Securities Remains a Buy on Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145)

CHICMAX issued a profit warning, expecting profits for the fiscal year 2025 to be between RMB 1.14 billion and RMB 1.16 billion, an increase of 41.9%-44.4% compared to the previous year; revenue is expected to be between RMB 9.1 billion and RMB 9.2 billion, an increase of 34%-35.4%. This is mainly due to the successful layout of the group's multi-brand and multi-category strategy, the continuous growth of revenue from the scientific anti-aging skincare brand Han Shu, and the significant increase in revenue from the Chinese infant and toddler efficacy skincare brand newpage

"Profit Alert" CHICMAX forecasts over 1.1 billion RMB in earnings last year, an increase of 42%-44%

CHICMAX(02145.HK)